Leukemia chemotherapy in Thailand typically costs from AUD $21,628 / ฿A735,345 to AUD $31,721 / ฿A1,078,506. The final price depends on the leukemia subtype, drug cycles, and hospital choice. Patients save around 73% compared to Australia, where average costs are AUD $97,037 / ฿A3,299,248. Standard care usually includes oncologist consultations, chemotherapy administration, and basic monitoring during your stay in Bangkok or Pattaya.
Bookimed Expert Insight: Choosing a multidisciplinary hub like Bumrungrad International Hospital provides access to 1,300 doctors and JCI-accredited safety. While top-tier private hospitals in Bangkok charge a premium, they offer integrated hematology departments. This eliminates the need for external testing, which often reduces the overall length of stay. Facilities like Bangkok Hospital Pattaya are excellent options for those seeking specialist care outside the capital.
| Thailand | Turkey | South Korea | |
| Leukemia chemotherapy | from AUD $21,628 / ฿A735,345 | from AUD $11,535 / ฿A392,184 | from AUD $31,721 / ฿A1,078,506 |
No hidden fees – just official clinic prices. Pay at the clinic for Leukemia chemotherapy upon arrival and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Leukemia chemotherapy and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Leukemia chemotherapy journey.
Dr Kodchanut Litleaungdej is a Thai Board-certified haematologist at Intrarat Hospital who graduated with second-class honours from Naresuan University.
Dr. Nichakorn Seehirunwong is a diagnostic radiologist at Intrarat Hospital in Bangkok. She specializes in interpreting medical imaging results and informing complex treatment plans. Dr. Seehirunwong earned her medical degree from the Prince of Songkla University. She also completed her diagnostic radiology certification at the same institution.
Thailand provides high-quality leukaemia care through JCI-accredited hospitals specialising in haematology and oncology. These facilities offer chemotherapy and bone marrow transplants using pathology and diagnostic tools. International patients benefit from immediate treatment access. This helps them avoid long wait times common in Western public health systems.
Bookimed Expert Insight: Thailand’s private sector is geared toward international patients. Bumrungrad reports that 50% of its 1,000,000 annual patients arrive from abroad. This high volume means nursing teams and pathology labs are highly experienced. They specialise in managing leukaemia complications like neutropenic fever and urgent transfusions.
Patient Consensus: Real experiences in Thailand centre on the efficiency of private tertiary hospitals. Patients also highlight the importance of identifying a dedicated haematology team. They recommend confirming that pathology results and medical records will be shared digitally. This helps their Australian oncologists provide future support.
Leading leukaemia specialists in Thailand work mostly in JCI-accredited haematology centres in Bangkok. Top experts include Dr Surasit Saleh Issarachai and Dr Narin Voravud at Bumrungrad International Hospital. Dr Kodchanut Litleaungdej at Intrarat Hospital is another Thai Board-certified specialist. These doctors specialise in intensive chemotherapy and bone marrow transplants.
Bookimed Expert Insight: While Bangkok is the primary hub, Bumrungrad International Hospital is a standout for Australians. Data reveals it has a 50% international patient share and a Newsweek world ranking. Their haematologists manage rare leukaemia subtypes more often than most general oncologists.
Patient Consensus: Patients suggest asking haematologists about their case volume for your specific leukaemia subtype. They also recommend checking that the hospital has dedicated infectious disease and transfusion services.
Top hospitals for leukaemia treatment in Bangkok include Bumrungrad International Hospital and Bangkok Hospital. Both hold JCI accreditation. These facilities provide haematology services, including chemotherapy and bone marrow transplants. Specialist centres like Intrarat Hospital also offer dedicated haematology-oncology care with Thai Board-certified specialists.
Bookimed Expert Insight: Bookimed data shows that 50% of patients at Bangkok’s leading hospitals are international. This high volume means facilities like Bumrungrad have efficient systems for English-speaking patients. For Australians, this often includes telehealth follow-up options and medical records provided in English for their GP.
Patient Consensus: Patients recommend choosing large private hospitals in Thailand with on-site blood transfusion support. They also suggest hospitals with rapid pathology turnaround. Patients prefer securing a named specialist to lead the treatment plan for better continuity between chemotherapy cycles.
Leukaemia chemotherapy in Thailand typically starts with a four-week intensive induction phase as an inpatient. Depending on the leukaemia type, the full treatment course can span one to three years. Major Bangkok hospitals specialise in these long-term protocols for international patients.
Bookimed Expert Insight: While chemotherapy starts at $2,000, full induction cycles in Thailand range from $15,000 to $22,000. JCI-accredited centres like Bumrungrad International Hospital serve over 1 million patients annually. These hospitals provide dedicated visa support for 12-month care plans.
Patient Consensus: Patients find the 90-day medical visa essential for starting induction therapy in Thailand. They appreciate that Bangkok hospitals coordinate accommodation and interpreters for the long maintenance phases.
CAR T-cell therapy is available in Thailand for leukaemia and lymphoma patients. Major Bangkok centres provide this immunotherapy. These include Chulalongkorn University and specialised private hospitals. Access occurs through clinical trials or compassionate use programs. These programs treat specific haematological malignancies in both children and adults.
Bookimed Expert Insight: Chemotherapy for leukaemia typically costs between $15,000 and $22,000 in Thailand. However, CAR T-cell therapy is a separate, higher-tier investment. Some Bangkok hospitals now offer telehealth follow-ups for international patients. This is vital for monitoring cytokine release syndrome after returning to Australia.
Patient Consensus: Patients suggest confirming whether the centre treats your specific leukaemia subtype before travelling. They also recommend asking about the vein-to-vein time for manufacturing cells while staying abroad.
Specialised cancer centres treat leukaemia in regional hubs like Pattaya, Chon Buri, and Phuket. Facilities like Bangkok Hospital Pattaya and Cancer Alliance Hospital provide haematology and chemotherapy. These centres maintain international accreditations, such as Joint Commission International (JCI), for high-level oncology care outside the capital.
Bookimed Expert Insight: Bangkok is the primary hub, but regional centres like Bangkok Hospital Pattaya handle 400,000+ patients annually. Board-certified haematologists like Dr Kodchanut Litleaungdej practise in areas such as Hua Hin. This confirms that tertiary-level blood cancer expertise is accessible in major coastal cities.
Patient Consensus: Patients suggest confirming a specialist haematologist-oncologist is on-site rather than a general specialist. They report that regional tertiary hospitals in Thailand effectively manage chemotherapy and blood transfusions in-house.